OGR

Lobbying for AMGEN USA INC

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $50,000.00 income · posted Oct 19, 2025

Lobbying activity 2

Medicare/Medicaid

Issues related to Medicare Part D and Medicare Part B reimbursement and coverage. Issues related to drug pricing. Issues related to biosimilar regulation.

Taxation/Internal Revenue Code

Issues related to Puerto Rico.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.